ALLISON LINTON: Open Payments
NPI 1528206018 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 24 payments from 16 companies in 2025. Trend: 2023 $642 · 2024 $949 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 3 | $62 |
| Novo Nordisk Inc | 3 | $57 |
| Lundbeck LLC | 2 | $48 |
| Astellas Pharma US Inc | 2 | $38 |
| UCB, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Madrigal Pharmaceuticals | 1 | $23 |
| CSL Behring | 1 | $16 |
Products named: JATENZO, VYEPTI, Veozah, Rystiggo, CAPLYTA, AIRSUPRA, TZIELD, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
